Literature DB >> 19926287

The role of microglia in central nervous system immunity and glioma immunology.

Isaac Yang1, Seunggu J Han, Gurvinder Kaur, Courtney Crane, Andrew T Parsa.   

Abstract

The central nervous system (CNS) historically has been considered an immune-privileged organ, lacking a lymphatic system and shielded from the circulatory system by the blood-brain barrier. Microglia are an abundant portion of the CNS cell population, comprising 5% to 20% of the total glial cell population, and are as numerous as neurons. A crucial function of microglia is the ability to generate significant innate and adaptive immune responses. Microglia are involved in first line innate immunity of the CNS. Proper antigen presentation is critical in the generation of specific, durable responses by the adaptive immune system, and requires interaction between the T cell receptor and processed antigen peptide presented on major histocompatibility complex (MHC) molecules by the antigen presenting cells (APC). Microglia also have a large regulatory role in CNS immunity. Histopathologic studies of glioma tissue have consistently shown high levels of infiltrating microglia. Microglia are also localized diffusely throughout the tumor, rather than to the areas of necrosis, and phagocytosis of glioma cells or debris by microglia is not observed. Recent evidence indicates that glioma-infiltrating microglia/macrophages might be promoting tumor growth by facilitating immunosuppression of the tumor microenvironment. When activated, microglia can be potent immune effector cells, able to perform a broad range of functions, and they mediate both innate and adaptive responses during CNS injury and disease while remaining quiescent in the steady state. Their versatility in bridging the gap between the immune-privileged CNS and the peripheral immune system, in addition to their significant numbers in gliomas, makes them an attractive candidate in immunotherapy for gliomas. An enhanced understanding of microglia-glioma interaction may provide better methods to manipulate the glioma microenvironment to allow the generation of a specific and durable anti-glioma immunity. The role of microglia in CNS immunity is reviewed, with a focus on key advances made in glioma immunology. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19926287      PMCID: PMC3786731          DOI: 10.1016/j.jocn.2009.05.006

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  98 in total

Review 1.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.

Authors:  E N Benveniste
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

2.  Distribution and characterization of microglia/macrophages in human brain tumors.

Authors:  W Roggendorf; S Strupp; W Paulus
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

3.  Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis.

Authors:  K B Nguyen; M P Pender
Journal:  Acta Neuropathol       Date:  1998-01       Impact factor: 17.088

4.  Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.

Authors:  B Badie; J M Schartner; J Paul; B A Bartley; J Vorpahl; J K Preston
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

Review 5.  Glioma immunology and immunotherapy.

Authors:  I F Parney; C Hao; K C Petruk
Journal:  Neurosurgery       Date:  2000-04       Impact factor: 4.654

6.  Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.

Authors:  Isaac Yang; Thomas J Kremen; Adrian J Giovannone; Elena Paik; Sylvia K Odesa; Robert M Prins; Linda M Liau
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

7.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

8.  Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess.

Authors:  Aaron C Baldwin; Tammy Kielian
Journal:  J Neuroimmunol       Date:  2004-06       Impact factor: 3.478

9.  Resident microglia from adult mice are refractory to nitric oxide-inducing stimuli due to impaired NOS2 gene expression.

Authors:  Courtney A Brannan; Margo R Roberts
Journal:  Glia       Date:  2004-11-01       Impact factor: 7.452

10.  Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection.

Authors:  L Liu; J K Persson; M Svensson; H Aldskogius
Journal:  Glia       Date:  1998-07       Impact factor: 7.452

View more
  137 in total

Review 1.  Microglial cell origin and phenotypes in health and disease.

Authors:  Kaoru Saijo; Christopher K Glass
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

Review 2.  Unique biology of gliomas: challenges and opportunities.

Authors:  Stacey Watkins; Harald Sontheimer
Journal:  Trends Neurosci       Date:  2012-06-08       Impact factor: 13.837

3.  A much convenient and economical method to harvest a great number of microglia.

Authors:  Kun Qin; Ye-Hai Li; Ge Tian; Wei-Wei Xu; Peng Li; Run Zhang; Zheng-Yang Li; Xiao-Dan Jiang
Journal:  Cell Mol Neurobiol       Date:  2011-07-16       Impact factor: 5.046

Review 4.  Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Authors:  Kurt M Kroeger; A K M Ghulam Muhammad; Gregory J Baker; Hikmat Assi; Mia K Wibowo; Weidong Xiong; Kader Yagiz; Marianela Candolfi; Pedro R Lowenstein; Maria G Castro
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

5.  miR-146a Dysregulates Energy Metabolism During Neuroinflammation.

Authors:  Sujung Jun Kim; Ashley E Russell; Wei Wang; Darren E Gemoets; Saumyendra N Sarkar; James W Simpkins; Candice M Brown
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-24       Impact factor: 4.147

6.  Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.

Authors:  Matt Weaver; Gail Workman; Chad R Schultz; Nancy Lemke; Sandra A Rempel; E Helene Sage
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 7.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

8.  Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.

Authors:  Zhihong Chen; Cameron J Herting; James L Ross; Ben Gabanic; Montse Puigdelloses Vallcorba; Frank Szulzewsky; Megan L Wojciechowicz; Patrick J Cimino; Ravesanker Ezhilarasan; Erik P Sulman; Mingyao Ying; Avi Ma'ayan; Renee D Read; Dolores Hambardzumyan
Journal:  Glia       Date:  2020-07-08       Impact factor: 7.452

Review 9.  Role of AHR and HIF-1α in Glioblastoma Metabolism.

Authors:  Galina Gabriely; Michael A Wheeler; Maisa C Takenaka; Francisco J Quintana
Journal:  Trends Endocrinol Metab       Date:  2017-03-16       Impact factor: 12.015

10.  Current status of gene therapy for brain tumors.

Authors:  Andrea M Murphy; Samuel D Rabkin
Journal:  Transl Res       Date:  2012-12-11       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.